WO2001055345A3 - Verfahren zur herstellung eines serumhaltigen kulturmediums für zellen sowie dessen verwendung - Google Patents

Verfahren zur herstellung eines serumhaltigen kulturmediums für zellen sowie dessen verwendung Download PDF

Info

Publication number
WO2001055345A3
WO2001055345A3 PCT/DE2001/000350 DE0100350W WO0155345A3 WO 2001055345 A3 WO2001055345 A3 WO 2001055345A3 DE 0100350 W DE0100350 W DE 0100350W WO 0155345 A3 WO0155345 A3 WO 0155345A3
Authority
WO
WIPO (PCT)
Prior art keywords
cells
culture medium
producing
serum
document
Prior art date
Application number
PCT/DE2001/000350
Other languages
English (en)
French (fr)
Other versions
WO2001055345A2 (de
Inventor
Gerhard Becker
Susanne Koch
Carl Thomas Nebe
Original Assignee
Sanorell Pharma Gmbh & Co
Gerhard Becker
Susanne Koch
Carl Thomas Nebe
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanorell Pharma Gmbh & Co, Gerhard Becker, Susanne Koch, Carl Thomas Nebe filed Critical Sanorell Pharma Gmbh & Co
Priority to AU2001240445A priority Critical patent/AU2001240445A1/en
Publication of WO2001055345A2 publication Critical patent/WO2001055345A2/de
Publication of WO2001055345A3 publication Critical patent/WO2001055345A3/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0018Culture media for cell or tissue culture
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/96Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood or serum control standard

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

Es wird ein Verfahren zur Herstellung eines serumhaltigen Kulturmediums für Zellen, insbesondere Human- und Tierzellen, beschrieben, bei dem das Kulturmedium und/oder das Serum mittels einer Ultrfiltrationsmembran gefiltert wird. Vorzugsweise wird die Abreicherungsrate der Filtrationsmembran mittels Viren der Familie Leviviridae bzw. vergleichbar kleiner Bakteriophagen bestimmt. Das so erhaltene Kulturmedium wird zur Kultivierung von natürlichen und rekombinanten Zellen sowie von Hybridomazellen, sowie zur Herstellung von diagnostischen Kontrollseren, insbesondere zur Herstellung von pharmazeutischen und/oder diagnostischen Präparaten verwendet.

Description

lr national Application No
PlT/DE 01/00350
A CLASSIFICATION OF SUBJECT MATTER
IPC 7 C12N5/00 G01N33/96 C12P1/00 //( C12P1/00 , C12R1 : 91 )
According lo International Patent Classihcalion (IPC) or lo bolh national classificalion and IPC
B. F1ELDS SEARCHED
Minimum documentation searched (classitication System tollowed by classitication Symbols)
IPC 7 C12N
Documentation searched olher lhan minimum documenlation to the extent that such documents are included in the Neids searched
Electronic data base consulted dunng Ihe international search (name ot data base and where practical search terms used)
EPO-Internal , WPI Data , PAJ , MEDLINE , CHEM ABS Data , EMBASE , LIFESCIENCES
C. DOCUMENTS CONSIDERED TO BE RELEVANT
Category " Citation ot document wilh indicalion where appropπate ot the relevant passages Relevant to Claim No
JUNGBAUER , A . ET AL : "Cross fl ow 1-3 , 8, 9 di afi l trati on of seru wi th basal medi um suitable for growth of hybri do as , steri l i zati on and protei n reducti on . ADVANCES IN ANIMAL CELL TECHNOLOGY : CELL ENGINEERING , EVALUATION AND EXPLOITATION . " , DEV . BIOL . STAND . , ( 1987) PP . 87-90. MEETING INFO . : 7. GENERAL MEETING 0F ESACT ON ANIMAL CELL TECHNOLOGY : CELL ENGINEERING , EVALUATION AND EXPLOITATION . BADEN (AUSTRIA) . 30 SEP-4 0CT 1985. ISBN : 3-8055-4556-8. , INST . APPL. MICROBIOL . , UNIV . AGRIC , PETER-JORDANSTR . 82 , A-1190 VIENNA, AUSTRIA XP001015674 the whol e document 4-7
7~
Furlher documents are Iisted in the continuation ot box C El Patent tamily members are Iisted in annex
° Special categoπes ot cited documents
"T" later document published after the international tilmg dale or pπority date and not in contlict with the application but
"A" document defming the general State of the art which is not cited to understand the pnnciple or theory underlying Ihe considered to be ot particular relevance invention Ε" earlier document bul published on or after the international "X" document ot particular relevance the claimed invention filing date cannol be considered novel or cannol be considered to "L" document which may throw doubts on prioπty claιm(s) or mvolve an inventive step when the document is taken alone which is cited to establish Ihe publicalion date of another "Y" document of particular relevance the claimed invention citalion or other Special reason (as specified) cannot be considered to mvolve an inventive step when the
O" document reterring to an oral disclosure use exhibilion or document is combined with one or more other such docuother means ments such combination being obvious lo a person skilled "P" document published pπor to the international filing date but in the art later than the prioπty date claimed "&' document member of the same patenl tamily
Date ot Ihe actual completion ot the international search Date ot mailing of the international search report
9 August 2001 22/08/2001
Name and mailing address ot the ISA Authoπzed officer
European Patent Office P B 5818 Patentlaan 2 NL - 2280 HV Ri|swi|k Tel (+31-70) 3 0-20 0 Tx 31 651 epo nl Fax (+31-70) 3*10-3016 Stei n , A
Form PCT ISA/210 (second Sheet) (July W2) In national Application No
PtT/DE 01/00350
C.(Contιnuation) DOCUMENTS CONSIDERED TO BE RELEVANT
Calegory Citation ot document, with indicalion, where appropriale, ol Ihe relevant passages Relevanl to Claim No
DE 44 29 558 A (SANORELL PHARMA GMBH & CO) 4-7 22 February 1996 (1996-02-22) the whole document
DE 41 26 034 C (SANORELL PHARMA GMBH & CO) 6,7 10 September 1992 (1992-09-10) column 1, line 1 - 1 ine 30 colu n 2, line 38 - line 57 column 4, line 19 - line 42 clai 1
DE 24 20 415 A (RES FOUNDATION OF CHILDREN 1,2,8
5 H ) 14 November 1974 ( 1974-11-14 ) The whole document in particular example 1
DATABASE WPI 1,8
Section Ch, Week 198249
Derwent Publications Ltd., London, GB;
Class D16, AN 1982-06697J
XP002174522
6 SU 905 281 A (AS USSR BIOLOG PHYS), 18 February 1982 (1982-02-18) abstract
LEGGETT J.E. ET AL: "Use of serum 8-10 ultrafiltrate in the serum dilution test." JOURNAL OF INFECTIOUS DISEASES, (1989) 160/4 (616-623). ,
XP001015678 the whole document
Form PCT'ISA'210 (conlinuatioπ of second sheet) (July 1992) In* national Vpphcation No
Information on patent family members
F- /DE 01/00350
Patent document Publication Patent family Publication cited in search report date member(s) date
DE 4429558 A 22-02-1996 AT 180672 T 15-06-1999 AU 3252095 A 14-03-1996 O 9605846 A 29-02-1996 DE 59506111 D 08-07-1999 DK 776212 T 29-11-1999 EP 0776212 A 04-06-1997 ES 2135079 T 16-10-1999 GR 3030688 T 30-11-1999
DE 4126034 C 10-09-1992 AT 147274 T 15-01-1997 AU 2473392 A 02-03-1993 CA 2115069 A 18-02-1993 O 9302714 A 18-02-1993 DE 59207860 D 20-02-1997 EP 0599981 A 08-06-1994 US 5731164 A 24-03-1998
DE 2420415 A 14-11-1974 AU 6837174 A 30-10-1975 FR 2227276 A 22-11-1974 JP 50029739 A 25-03-1975 NL 7405707 A 29-10-1974
SU 905281 A 15-02-1982 NONE
PCT/DE2001/000350 2000-01-28 2001-01-26 Verfahren zur herstellung eines serumhaltigen kulturmediums für zellen sowie dessen verwendung WO2001055345A2 (de)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2001240445A AU2001240445A1 (en) 2000-01-28 2001-01-26 Method for producing a serum-containing culture medium for cells and the use thereof

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10003811.5 2000-01-28
DE2000103811 DE10003811A1 (de) 2000-01-28 2000-01-28 Verfahren zur Herstellung eines serumhaltigen Kulturmediums für Zellen sowie dessen Verwendung

Publications (2)

Publication Number Publication Date
WO2001055345A2 WO2001055345A2 (de) 2001-08-02
WO2001055345A3 true WO2001055345A3 (de) 2002-02-28

Family

ID=7629107

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/DE2001/000350 WO2001055345A2 (de) 2000-01-28 2001-01-26 Verfahren zur herstellung eines serumhaltigen kulturmediums für zellen sowie dessen verwendung

Country Status (3)

Country Link
AU (1) AU2001240445A1 (de)
DE (1) DE10003811A1 (de)
WO (1) WO2001055345A2 (de)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2420415A1 (de) * 1973-04-27 1974-11-14 Res Foundation Of Children S H Eine mitogenische blutfraktion und verfahren zur herstellung derselben
SU905281A1 (ru) * 1980-03-03 1982-02-15 Институт биологической физики АН СССР Способ хранени культур клеток животных и человека
DE4126034C1 (de) * 1991-08-06 1992-09-10 Sanorell Pharma Gmbh & Co, 7292 Baiersbronn, De
DE4429558A1 (de) * 1994-08-19 1996-02-22 Sanorell Pharma Gmbh & Co Verfahren zur Herstellung von infektionsfreien pharmazeutischen Präparaten und/oder Nahrungsmitteln aus infektiösem Material

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH04500076A (ja) * 1988-08-15 1992-01-09 ブリガム・アンド・ウイメンズ・ホスピタル 白血球付着阻害物質

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2420415A1 (de) * 1973-04-27 1974-11-14 Res Foundation Of Children S H Eine mitogenische blutfraktion und verfahren zur herstellung derselben
SU905281A1 (ru) * 1980-03-03 1982-02-15 Институт биологической физики АН СССР Способ хранени культур клеток животных и человека
DE4126034C1 (de) * 1991-08-06 1992-09-10 Sanorell Pharma Gmbh & Co, 7292 Baiersbronn, De
DE4429558A1 (de) * 1994-08-19 1996-02-22 Sanorell Pharma Gmbh & Co Verfahren zur Herstellung von infektionsfreien pharmazeutischen Präparaten und/oder Nahrungsmitteln aus infektiösem Material

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
DATABASE WPI Section Ch Week 198249, Derwent World Patents Index; Class D16, AN 1982-06697J, XP002174522 *
JUNGBAUER, A. ET AL: "Cross flow diafiltration of serum with basal medium suitable for growth of hybridomas, sterilization and protein reduction. ADVANCES IN ANIMAL CELL TECHNOLOGY: CELL ENGINEERING, EVALUATION AND EXPLOITATION.", DEV. BIOL. STAND., (1987) PP. 87-90. MEETING INFO.: 7. GENERAL MEETING OF ESACT ON ANIMAL CELL TECHNOLOGY: CELL ENGINEERING, EVALUATION AND EXPLOITATION. BADEN (AUSTRIA). 30 SEP-4 OCT 1985. ISBN: 3-8055-4556-8., INST. APPL. MICROBIOL., UNIV. AGRIC., PETER-JORDANSTR. 82, A-1190 VIENNA, AUSTRIA, XP001015674 *
LEGGETT J.E. ET AL: "Use of serum ultrafiltrate in the serum dilution test.", JOURNAL OF INFECTIOUS DISEASES, (1989) 160/4 (616-623)., XP001015678 *

Also Published As

Publication number Publication date
WO2001055345A2 (de) 2001-08-02
DE10003811A1 (de) 2001-08-09
AU2001240445A1 (en) 2001-08-07

Similar Documents

Publication Publication Date Title
DE60028989T3 (de) Medium für die protein- und serumfreie zellkultur
De Felici et al. Isolation of mouse primordial germ cells
DE69634407T2 (de) DEM ANTI-GENOM VON NICHT-SEGMENTIERTEN MINUSSTRÄNGEN RNA-VIREN ENTSPRECHENDE cDNA UND VERFAHREN ZUR HERSTELLUNG SOLCHER VIREN, WELCHE ZUSÄTZLICH ANTIGENISCH AKTIVE PROTEINE KODIEREN
CA2148934C (en) Targetable vector particles
DE60112050T2 (de) Rekombinantes influenza a virus
DE3886363T3 (de) NANBV-Diagnostika
Tsurykau A provisional checklist of the lichens of Belarus
DE69432231T2 (de) Peptide mit antithrombotischer aktivität und verfahren zu ihrer herstellung
CN105567738A (zh) 使用基因组编辑技术CRISPR-Cas9诱导CCR5Δ32缺失的方法
CA1341433C (en) Purification of interleukin 1
CA2259965A1 (en) Hiv envelope polypeptides and vaccine
DE3788807T2 (de) Fusionsproteine und -partikel.
DE69535680T2 (de) Sekretierte, als impfstoffe und diagnostika verwendbare virale cmv-proteine
EP1851239A1 (de) Replikationsdefiziente rna-viren als impfstoffe
Kurstak Invertebrate Tissue Culture: Applications in Medicine, Biology, and Agriculture
DE69933528T2 (de) Verfahren zur Cytokinproduktionn unter Verwendung eines Sendai Virus Expressionssystems
AT502275A1 (de) Immunantwort-induzierende zusammensetzungen
WO2001055345A3 (de) Verfahren zur herstellung eines serumhaltigen kulturmediums für zellen sowie dessen verwendung
Porter Origins of new queens in polygyne red imported fire ant colonies (Hymenoptera: Formicidae)
Wheeler Jr et al. An annotated list of the Miridae of West Virginia (Hemiptera-Heteroptera)
Zavada et al. Comparative pollen wall development of Welwitschia mirabilis and selected primitive angiosperms
CN109897826A (zh) 重组细胞及制备方法、外源基因定点整合到cho细胞基因组的方法及试剂盒、重组细胞株
EP1169461B1 (de) Verwendung von pankreatischer Procarboxypeptidase B zur Herstellung von Insulin
CA2161645A1 (en) Recombinant antigens from mumps virus and their use in vaccines
Quinkal et al. Mapping of the interaction between the immunodominant loop of the ectodomain of HIV‐1 gp41 and human complement protein C1q

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP